Skip to main content
Clinical Trials/NCT00004980
NCT00004980
Completed
Phase 2

Repetitive Transcranial Magnetic Stimulation of Speech Processing Brain Areas in Schizophrenic Patients Who Hear "Voices"

Yale University1 site in 1 country50 target enrollmentDecember 1999
ConditionsSchizophrenia

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Yale University
Enrollment
50
Locations
1
Primary Endpoint
Hallucination Change Score (HCS) After 9 Active/Sham rTMS Sessions
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

OBJECTIVES:

I. Determine the effect of repetitive transcranial magnetic stimulation on treatment refractory auditory hallucinations of patients with schizophrenia.

Detailed Description

PROTOCOL OUTLINE: This is a randomized, double blind study. Patients are randomized to one of two treatment arms. Group I: Patients receive 9 sessions of active transcranial magnetic stimulation (rTMS) which consists of 8 minutes of rTMS during session 1, 12 minutes duration during session 2, and 16 minutes duration during sessions 3-9. The total duration of stimulation is 132 minutes. Each session was given on a separate day and in general each session occurred on consecutive days with the exception of weekends. Group II: Patients receive 9 sessions of sham stimulation, which consists of 8 minutes of sham stimulation during session 1, 12 minutes duration sham stimulation during session 2, and 16 minutes duration sham stimulation during sessions 3-9. The total duration of sham stimulation is 132 minutes. Each session was given conducted on a separate day and in general each session occured on consecutive days with the exception of weekends. This study provided pilot data supplying the basis for our current study - NCT00308997 -- see our website for details

Registry
clinicaltrials.gov
Start Date
December 1999
End Date
June 2005
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Hallucination Change Score (HCS) After 9 Active/Sham rTMS Sessions

Time Frame: After the 9th active/sham rTMS session (up to 2 weeks or end of intervention)

Change in hallucination severity relative to baseline with scores ranging 1 in unit intervals to 20 anchored as follows: 0=hallucinations stopped, 10=no change, 20=hallucinations twice as severe as baseline

Secondary Outcomes

  • Change From Baseline in Hallucination Frequency After 9 Active/Shame rTMS Sessions(After the 9th active/sham rTMS session (up to 2 weeks or end of intervention))
  • Clinical Global Improvement (CGI) Scale After 9 Active/Shame rTMS Sessions(After the 9th active/sham rTMS session (up to 2 weeks or end of intervention))
  • Responder Status(After the 9th active/sham rTMS session (up to 2 weeks or end of intervention))

Study Sites (1)

Loading locations...

Similar Trials